Managed Care
Disease
Management

Clinical Brief: Safety of Lipid-Lowering Therapies

Clinical Brief: Safety of Lipid-Lowering Therapies

This Brief summarizes four studies that examine the safety of HMG-CoA reductase inhibitors (statins). It also includes an analysis for MCOs by Steven R. Peskin, MD, MBA.

Highlights:

  • The Report of the National Lipid Association Statin Safety Task Force
  • International Studies on the Comparative Safety of Rosuvastatin

Meetings

Medical Devices Summit Boston, MA February 19–20, 2015
3rd Annual Summit to Improve Adherence and Enhance Patient Engagement Philadelphia, PA March 9–10, 2015
Value-Added Solutions for Enhanced Customer Experience Philadelphia, PA March 9, 2015